(Q36593078)

15 August 2017

1 reference

title

Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists (English)

1 reference

15 August 2017

0 references

Noah Scheinfeld

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Journal of Dermatological Treatment

15 August 2017

published in

1 reference

15 August 2017

volume

17

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

229-234

1 reference

Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Selective costimulation modulators: a novel approach for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Between adaptive and innate immunity: TLR4-mediated perforin production by CD28null T-helper cells in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

CTLA4Ig: a novel inhibitor of costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhi CD4+ T cells correlates with suppression of psoriasis and colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

CTLA4-Ig: a novel immunosuppressive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630600788885

10.1080/09546630600788885

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference